Weighing the evidence for infection as a risk factor for coronary heart disease

被引：12

作者：

O'Donnell C.J. ^{[1
]}

Levy D. ^{[1
]}

机构：

[1] Framingham Heart Study, Framingham, MA 01702

来源：

Current Cardiology Reports | 2000年 / 2卷 / 4期

关键词：

Coronary Heart Disease; Azithromycin; Coronary Heart Disease Risk; Traditional Risk Factor; Roxithromycin;

D O I：

10.1007/s11886-000-0082-6

中图分类号：

学科分类号：

摘要：

There has been considerable attention in recent years to the intriguing hypothesis that coronary heart disease and other atherosclerotic diseases may be caused by infection with pathogens such as Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus. Supporting this hypothesis are studies that localize bacterial antigens to atherosclerotic plaques and that draw associations of systemic inflammation and chronic infections with coronary disease. Although there are several examples of positive associations of pathogen seropositivity with disease, recent prospective follow-up studies of infection seropositivity have not generally supported these associations. At present, the evidence is insufficient to designate infection as a causal risk factor for coronary heart disease. The results of ongoing larger observational studies and antibiotic treatment trials may yield important information regarding the presence and magnitude of risk, if any, beyond that conferred by established coronary risk factors. Copyright © 2000 by Current Science Inc.

引用

页码：280 / 287

页数：7

共 47 条

[1]

2000 Heart and Stroke Statistical Update, (2000)

[2]

Danesh J., Collins R., Peto R., Chronic infections and coronary heart disease: Is there a link?, Lancet, 350, pp. 430-436, (1997)

[3]

Thom D.H., Wang S.P., Grayston J.T., Et al., Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease, Arterioscler Thromb, 11, pp. 547-551, (1991)

[4]

Patel P., Mendall M.A., Carrington D., Et al., Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors, Br Med J, 311, pp. 711-714, (1995)

[5]

Cook P.J., Honeybourne D., Lip G.Y., Et al., Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: The West Birmingham Stroke Project, Stroke, 29, pp. 404-410, (1998)

[6]

Ridker P.M., Kundsin R.B., Stampfer M.J., Et al., Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction, Circulation, 99, pp. 1161-1164, (1999)

[7]

Ridker P.M., Hennekens C.H., Buring J.E., Et al., Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women, Ann Intern Med, 131, pp. 573-577, (1999)

[8]

Ridker P.M., Hennekens C.H., Stampfer M.J., Wang F., Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke, Circulation, 98, pp. 2796-2799, (1998)

[9]

Haider A.W., Wilson P.W.F., Larson M.G., Et al., Association of H Pylori, C Pneumoniae and Cytomegalovirus Seropositivity with Cardiovascular Disease in the Framingham Heart Study [abstract], Circulation, 100, (1999)

[10]

Libby P., Egan D., Skarlatos S., Roles of infectious agents in atherosclerosis and restenosis: An assessment of the evidence and need for future research, Circulation, 96, pp. 4095-4103, (1997)

← 1 2 3 4 5 →